Can post-market evidence generation be streamlined? FDA-commissioned report proposes solutions - Endpoints
As the FDA seeks to bring a greater focus to improving post-market evidence generation, a new report from the Reagan-Udall Foundation offers some potential solutions to the system it says is too costly and complicated.